RJA
EOLS icon

Raymond James & Associates’s Evolus EOLS Stock Holding History

Raymond James & Associates’s Portfolio EOLS Stock Details EOLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-29,018
Closed -$353K – 3554
2019
Q4 		$353K Sell
29,018
-263
-0.9% -$3.71K ﹤0.01% 2980
2019
Q3 		$457K Buy
29,281
+12,046
+70% +$197K ﹤0.01% 2711
2019
Q2 		$252K Buy
+17,235
New +$342K ﹤0.01% 3106
2018
Q3 		– Sell
-11,681
Closed -$327K – 3665
2018
Q2 		$327K Buy
+11,681
New +$206K ﹤0.01% 2964

Other funds holding EOLS

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MP
MFN Partners Boston, Massachusetts $4.77B AUM 72.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Raymond James & Associates's EOLS Position: Q1 2020 in Review

Raymond James & Associates sold out of Evolus (EOLS) in Q1 2020, closing a stake of 29,018 shares — an estimated $353K sold.

Raymond James & Associates first reported a position in EOLS in Q2 2018 and held it in 4 quarters. The position peaked at $457K in Q3 2019. 105 funds tracked by Wall St. Rank hold EOLS as of Q1 2020.

  • Raymond James & Associates reported no remaining Evolus position as of Q1 2020 after selling out during the quarter.
  • Raymond James & Associates sold 29,018 Evolus shares in Q1 2020, an estimated $353K.
  • Raymond James & Associates first reported a position in Evolus in Q2 2018 and held it in 4 quarters.
  • Raymond James & Associates's Evolus position peaked at $457K in Q3 2019.
  • 105 funds tracked by Wall St. Rank held Evolus as of Q1 2020.

Based on Raymond James & Associates's 13F filing for Q1 2020, filed 21 Apr 2020.